Data Sheet 1_Diagnostic efficacy of remnant cholesterol inflammatory index in diabetic kidney disease: machine learning approaches.docx gan Xili Xie (16560302)

Pynciau:

FGFs in CKD gan Guillermo Gervasini (9650945)

Pynciau:

A Sequential Dual-Reagent Paper-Based Analytical Device with Structural Release Control for Point-of-Care Detection of Urinary <i>N</i>‑Acetyl-β‑<i>d</i>‑Glucosaminidase gan Jie Cheng (294193)

Pynciau:

Comparison of Severity Grade and Normal EMG Between First and Second EMG Assessments in dialysis group at T2. gan Arwa Yahyaoui (22683276)

Pynciau:

Comparison between pre-dialysis and dialysis groups regarding clinical features and biological findings. gan Arwa Yahyaoui (22683276)

Pynciau:

Factors associated with EMG improvement after 6 months of follow-up of the uremic neuropathy in patients having a pathological first EMG. gan Arwa Yahyaoui (22683276)

Pynciau:

Comparison of electrophysiological abnormalities between pre-dialysis and dialysis Groups among children (n = 31) having an End Stage Kidney Disease. gan Arwa Yahyaoui (22683276)

Pynciau:

Evolution of the pathological EMG in dialysis and no-dialysis group. gan Arwa Yahyaoui (22683276)

Pynciau:

Association between polyneuropathy presence and clinical/biological features during initial EMG in a 31-patient cohort. gan Arwa Yahyaoui (22683276)

Pynciau:

Participants’ follow-up between T1 and T2. gan Arwa Yahyaoui (22683276)

Pynciau:

Evolution of EMG parameters between first and second EMG among children having an End Stage Kidney Disease with an Uremic neuropathy (n = 24). gan Arwa Yahyaoui (22683276)

Pynciau: